Genome-Wide Divergence of DNA Methylation Marks in Cerebral and Cerebellar Cortices by Xin, Yurong et al.
Genome-Wide Divergence of DNA Methylation Marks in










1, Andrew J. Dwork





1Department of Psychiatry, Columbia University and The New York State Psychiatric Institute, New York, New York, United States of America, 2Department of Pathology
and Cell Biology, Columbia University College of Physicians and Surgeons, New York, New York, United States of America, 3Taub Institute for Research on the Aging Brain,
Columbia University College of Physicians and Surgeons, New York, New York, United States of America, 4School Of Medicine, University Ss. Cyril and Methodius, Skopje,
Macedonia, 5Macedonian Academy of Sciences and Arts, University Ss. Cyril and Methodius, Skopje, Macedonia
Abstract
Background: Emerging evidence suggests that DNA methylation plays an expansive role in the central nervous system
(CNS). Large-scale whole genome DNA methylation profiling of the normal human brain offers tremendous potential in
understanding the role of DNA methylation in brain development and function.
Methodology/Significant Findings: Using methylation-sensitive SNP chip analysis (MSNP), we performed whole genome
DNA methylation profiling of the prefrontal, occipital, and temporal regions of cerebral cortex, as well as cerebellum. These
data provide an unbiased representation of CpG sites comprising 377,509 CpG dinucleotides within both the genic and
intergenic euchromatic region of the genome. Our large-scale genome DNA methylation profiling reveals that the
prefrontal, occipital, and temporal regions of the cerebral cortex compared to cerebellum have markedly different DNA
methylation signatures, with the cerebral cortex being hypermethylated and cerebellum being hypomethylated. Such
differences were observed in distinct genomic regions, including genes involved in CNS function. The MSNP data were
validated for a subset of these genes, by performing bisulfite cloning and sequencing and confirming that prefrontal,
occipital, and temporal cortices are significantly more methylated as compared to the cerebellum.
Conclusions: These findings are consistent with known developmental differences in nucleosome repeat lengths in cerebral
and cerebellar cortices, with cerebrum exhibiting shorter repeat lengths than cerebellum. Our observed differences in DNA
methylation profiles in these regions underscores the potential role of DNA methylation in chromatin structure and
organization in CNS, reflecting functional specialization within cortical regions.
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Introduction
5-methylcytosine (5mC), a minor base in mammalian DNA,
constitutes approximately 1% of DNA bases in the human
genome, predominately as symmetrical methylation of the
dinucleotide CpG [1]. The majority of methylated CpG
dinucleotides are found within repetitive DNA elements, suggest-
ing that cytosine methylation evolved as a mechanism for defense
against transposons and other parasitic elements [2]. DNA
methylation patterns change dynamically during development
and are essential for X-inactivation and monoallelic expression of
imprinted genes [3]. In somatic cells, promoter DNA methylation
is correlated with repression of gene expression, such that CpG
methylation may directly interfere with the binding of certain
transcriptional factors to their cognate DNA sequences or may
facilitate recruitment of methyl-CpG binding proteins that confer
a repressed chromatin state [4].
DNA methylation varies among different tissues, revealing
unique tissue-specific profiles. In the CNS, different DNA
methylation patterns have been observed across distinct brain
regions that included cerebrum, cerebellum, and pons [5].
Although this study was limited to 1,505 CpG sites confined
within a panel of 807 cancer related genes, the reported differences
appeared to be brain region specific and were not readily
attributed to inter-individual differences in DNA methylation
signatures [5,6]. The present study significantly extends the initial
efforts of Ladd-Acosta et al. (2007) [5] by (1) performing a large-
scale genomic study with 377,509 CpG sites, representing over
1.3% of CpG sites in the human genome, (2) providing an
unbiased genomic representation of CpG sites encompassing both
intergenic and genic regions, with 170,189 CpGs represented in
16,800 known genes, and (3) determining the extent of DNA
methylation in detail within prefrontal, occipital, and temporal
cerebral cortex and cerebellum. These data represent the first
PLoS ONE | www.plosone.org 1 June 2010 | Volume 5 | Issue 6 | e11357detailed investigation of the extent of DNA methylation signatures
in cerebral as compared to cerebellar cortices.
Such a large-scale genomic investigation is costly and time-
consuming; hence we selected a small panel of well-characterized
brain samples for DNA methylation profiling. The subjects were
selected from our postmortem human brain collection with
complete neuropathological and psychological data, as well as
brain toxicology reports, all confirming the absence of neuropsy-
chiatric disorders, pathological lesions, and psychoactive substanc-
es [7]. DNA methylation patterns were examined within these
normal brains for four distinct regions, including prefrontal cortex,
the occipital and temporal poles, and cerebellum. We used
methylation-sensitive SNP chip analysis (MSNP) [8] to assess
methylation patterns of these four brain regions. Our data reflects
divergent DNA methylation profiles in the three regions of the
cortex compared to the cerebellum, with cortex being significantly
more methylated than cerebellum. These differences at selected
loci reveal the potential role of DNA methylation in functional
specialization of the brain.
Results
We interrogated the DNA methylation status of 51,493 probes
throughout the human genome, covering 377,509 CpG dinucle-
otides, with the 250K-NspI Affymetrix chip. A total of 97 250K-
NspI chips were analyzed with at least two biological replicates for
each sample and experimental condition. In addition to the four
brain regions (i.e., prefrontal, occipital, temporal cerebral cortex
and cerebellum), we also examined DNA methylation profiles
within independent samples of human placenta, testes, and
peripheral blood to determine whether the observed DNA
methylation patterns were brain-specific. Unsupervised hierarchi-
cal clustering of the methylation (MI) scores revealed that the
samples cluster by tissue and brain region (Figure S1). This tissue
specificity in DNA methylation profiles is consistent with previous
findings [9,10]. Of note, is the striking hypomethylation of the
placenta and cerebellum relative to other tissues and brain regions
examined–though with distinct representation of hypomethylated
probes in the two tissues.
Further, the brain-specific methylation signatures revealed that
cerebellum is hypomethylated compared with prefrontal, occipital,
and temporal regions of the cortex (Figure 1). The distribution of
the MI scores shows a striking hypomethylated peak for the
cerebellum samples, whereas the samples from the cortex show a
shift in the corresponding peak in the hypermethylated direction
(Figure 1A). Overall, the three regions of the cortex grouped
together. The occipital and temporal regions of the brain clustered
by subject rather than by region (Figure 1B). Such inter-individual
methylation variability is perhaps not surprising, since the occipital
and temporal sensory regions of the brain are subject to
experience-based plasticity [11,12]. Moreover, 41% of the probes
covering 170,189 CpG sites, are located in genic regions with 97%
of CpGs in gene bodies and 4.3% in promoter regions. Although
the aim of this study was to examine the extent of DNA
methylation genome-wide, we also examined the extent of DNA
methylation within these genic regions to investigate if there are
differences in DNA methylation patterns between genic and
intergenic regions. Cluster analysis of genic probes also showed the
same clustering pattern, with cerebellum hypomethylated (supple-
mentary Figure S2).
To determine which probes significantly differentiate cerebral
and cerebellar cortices, we used a linear mixed-effects model to
identify 9,661 such probes with p#0.001 corrected for multiple
testing (supplementary Figure S3 and Table S2). Unsupervised
cluster analysis of these differentially methylated probes still
showed striking hypomethylation within cerebellum. The distri-
bution of the MI scores also still retained the hypomethylated peak
for the cerebellum samples, and as expected the methylation
differences between the cerebellum and prefrontal, occipital, and
temporal cortical samples became far more sharply defined after
this analysis (Figure S3A). The majority of these probes were
hypomethylated in cerebellum as compared to the three cortical
regions. We next identified those probes that were significantly
hypomethylated in cerebellum relative to prefrontal, occipital, and
temporal regions of the cortex. A total of 1,574 significant probes,
including 788 genic probes, were found with p#0.001 corrected
for multiple testing (Table S3). In contrast, only 147 probes exhibit
the opposite trend, with cerebellum hypermethylated as compared
with the three cortical regions.
Examination of the genic probes identified 113 genes with
distinct CNS function, determined by biological theme discovery
using Gene Ontology (GO) terms (supplementary Table S4).
These genes appear to be involved in diverse CNS functions,
including nervous system development, transmission of nerve
impulses, synaptic transmission, and neuron differentiation.
Importantly, we were able to independently validate the
microarray data by performing bisulfite cloning and sequencing
for four of these genes, randomly selected for validation. These
include NTRK3 (neurotrophic tyrosine kinase, receptor, type 3),
PTCH1 (patched homolog 1 (Drosophila)), SYNE1 (spectrin repeat
containing, nuclear envelope 1), and GRM4 (glutamate receptor,
metabotropic 4) within the four brain regions examined (see
Supplementary Materials S1 for experimental details). The
bisulfite sequencing results for these regions consistently validate
our predictions from the MSNP analysis and augment these data
by demonstrating coordinate involvement of multiple CpG
dinucleotides near the index HpaII sites, showing that cerebellar
cortex is hypomethylated as compared to three distinct regions of
the cerebral cortex (Figure 2). Though a minor concern, we
nevertheless conservatively performed the bisulfite cloning and
sequencing validation experiments using brain regions from the
same individuals to avoid potential confounds due to inter-
individual variability in DNA methylation signatures. Interest-
ingly, these genes, and others that we have identified in this study,
show cerebellum-specific activity (see supplementary Figure S4
for description of genes and their function in cerebellum). These
data reflect relative differences in DNA methylation levels, which
may not directly influence gene expression within the tissues
examined. These results reveal that DNA methylation patterns
vary markedly between cerebral and cerebellar cortices and
further demonstrate that the genome of the cerebellum is
hypomethylated as compared to regions of the cerebral cortex,
suggesting a potential role for DNA methylation in brain
organization and function.
Discussion
The extent of DNA methylation varies widely across the
genome and different cells within the nervous system. Although
due to experimental limitations in the requisite amount of starting
DNA we did not investigate the DNA methylation profiles within
individual cell populations, it is possible that some of our findings
may be attributed to cellular heterogeneity in cortex and
cerebellum. Additionally, the inter-individual variability within
occipital and temporal cortices was larger than the tissue
variability. This may be due to technical limitations of the SNP
chip-based approach used for DNA methylation profiling. Still,
our findings are consistent with previous observations of the
Brain Methylation Divergence
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studies of global chromatin structure within neurons of the
cerebral cortex and cerebellum revealed that the nucleosome
repeat length (i.e., the spacing between adjacent nucleosomes)
correlates with developmental trajectories [13,14,15,16,17]. Nu-
cleosome repeat lengths change concomitant with terminal
differentiation. In rat cortical neurons, the chromosome repeat
length shortens rapidly towards the end of the second postnatal
week, coinciding with neuronal maturation [15]. In contrast,
cerebellar neurons exhibit short repeat lengths at late fetal and
early postnatal stages and lengthen to adult levels about 30 days
postnatally [15]. These studies suggest that chromatin architecture
is plastic during development, but may no longer be dynamic in
adulthood. Our data profile DNA methylation patterns in adult
tissue, and may represent the endpoint of the developmental
methylation trajectory of cerebral and cerebellar cortices. The
striking differences we observe in DNA methylation in cerebellum
and regions of the cerebral cortex may contribute to functionally
relevant differences in chromatin architecture.
In mammalian cells, methyl-CpGs throughout the genome are
recognized by methyl binding proteins. Methyl-CpG binding
proteins represent an important class of chromosomal proteins
that associate with multiple protein partners to modify surround-
ing chromatin and to silence transcription, providing a functional
link between DNA methylation and chromatin remodeling and
modification. The molecular function of these proteins depends on
their ability to recognize and bind methylated DNA in a site-
specific manner. Bound methyl-CpG binding proteins establish
silent chromatin states by forming co-repressor complexes with
histone deacetylases and methylases to confer chromatin compac-
tion, leading to transcriptional repression [4,18].
Examination ofourgenome-wide methylationdata inthecontext
of previously published gene expression data inthe prefrontal cortex
and the cerebellum [19] suggests intriguingtrends. Genes with CpG
sites within promoters and gene bodies that are hypomethylated in
cerebellum relative to the cortex had a bimodal distribution
corresponding to a low and high pattern of gene expression (Figure
S5). The proportion of highly expressed genes is greater in
cerebellum, which is hypomethylated relative to the cortex. In
contrast, the low expressed genes appear to be enriched in the
cortex (Figure S5) as compared to the cerebellum. These trends are
consistent with the expected role of promoter DNA methylation in
transcriptional repression. Yet, in our data the majority of CpG sites
reside within gene bodies and intergenic regions and may not be
directly associated with expression of proximal gene(s). In a recent
genome-wide study, highly expressed genes were found to have
hypomethylated promoters and hypermethylated gene bodies [20].
Further, it has been reported that CpG methylation may influence
gene expression long range, with some tissue-specific differentially
methylated regions having been observed up to 3MB away from
CpG islands within gene bodies and upstream transcription start
sites [10]. The influence of CpG methylation within genomic
regions that are not immediate to promoters or transcription start
sites is still poorly understood, however methylation at these sites is
likely highly critical in chromatin remodeling and thus genome
organization and function.
Figure 1. Methylation pattern of 12,180 probes. (A) Brain MI score distributions showing cerebellum samples with bimodal distributions in red
and other brain regions in black. (B) Hierarchical clustering of methylation data. The heat map shows relative methylation differences depicted in (red)
hypomethylated and (blue) hypermethylated log2(MI) scores (rows and columns corresponding to probes and samples, respectively). Dendrogram
depicts clustering of samples by brain regions, where regions from the same subjects are color-coded.
doi:10.1371/journal.pone.0011357.g001
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in regions of cerebral cortex and cerebellum highlight the impact
of DNA methylation on higher-order chromatin structure. Such
regional differences in DNA methylation were likely acquired
developmentally as part of brain functional specialization,
underscoring the potential role of DNA methylation in brain
development and neuronal differentiation. Investigation of DNA
methylation during cortical development has revealed that these
patterns are dynamic, indicating methylation alterations in CpG
island promoters of genes involved in CNS growth and
development [21]. Taken together, these findings suggest that
DNA methylation, in concert with other chromatin remodeling
factors, maybe essential in mediating global morphological and/or
functional changes during neuronal differentiation and develop-
ment. Proper establishment and maintenance of DNA methylation
marks early in neurodevelopment can mediate proper maturation
of the complex neurocircuitry in cerebellum and prefrontal,
occipital, and temporal cortices, influencing gene expression and
ultimately brain function and behavior.
Materials and Methods
Ethics Statement
Genomic DNA from normal human tissue specimens with
anonymized identifiers was used under exemption by the
Columbia University and New York State Psychiatric Institute
institutional review board.
Samples and Subjects
We examined a total of 18 samples, consisting of 12 brain
samples and six samples that include two each of placenta, testes,
and peripheral blood. The non-CNS specimens were each
obtained from independent subjects. The 12 brain samples studied
were derived from four regions (cerebellum, occipital, temporal,
and ventral frontal cortices) of 5 brains (Table S1), consisting of
four males, average age 3662 years, and one female, age 41. Brain
pH ranged from 5.84 to 6.79, and the average postmortem
interval (PMI) was 1463.8 hours. Methylation patterns did not
differ significantly by age, sex, pH, and PMI within specimens
examined. The brains were derived from forensic autopsies. With
informed consent, family members were interviewed for a
psychological autopsy to obtain demographic information and
any evidence of psychiatric or somatic disease. The right cerebral
hemisphere was sliced coronally at intervals of 2–5 cm, and the
slices were rapidly frozen in Freon (dichlorodifluoromethane or
1,1,1,2 tetrafluoroethane), as were the cerebellum and brainstem.
Frozen specimens were then stored at 280uC until use. Most of
the left cerebral hemisphere was fixed in phosphate-buffered
formalin for diagnostic and other histological studies. For the
current study, slices were warmed to no more than 220uC, and
samples of ,200–500 mg were cut with a scalpel from folia of the
right superior and inferior semilunar lobules of the cerebellum,
and cerebral cortex from the caudal end of the right superior
occipital gyrus, the lateral aspect of the rostral end of the right
superior temporal gyrus, and the rostral end of the right gyrus
rectus and orbital gyrus. Samples were kept at 280uC until further
processing.
MSNP Procedure
We describe this procedure here only briefly because we have
previously reported the MSNP method [8]. Genomic DNA was
purified using the DNeasy Blood and Tissue Kit (Qiagen). We
Figure 2. Regional validation. Regional validation via bisulfite cloning and sequencing where the cerebellum is hypomethylated vs. the cerebrum
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the 250K NspI chip with the addition of an initial HpaII or MspI
digestion for the plus-HpaII and plus-MspI probes. Genomic DNA
(250 ng per representation) was digested with HpaII or MspIi na
total volume of 12 ml (Buffer 1, New England Biolabs) for 3 hrs,
followed by adjustment of the buffer by addition of 15.8 mlo f
water and 3.2 mlo f1 0 6Buffer 3 (New England Biolabs), a further
digestion with NspI for 3 hrs with NspI linkers ligated to the
restriction fragments, and PCR was carried out for 30 cycles with
linker primers. The same amount of genomic DNA was digested
with NspI only followed by PCR. We carried out PCR purification
using the DNA Amplification Clean-Up Kit (Clontech), and probe
fragmentation (brief exposure to DNase), biotin-labeling and
hybridization as described in the Affymetrix protocol. We
determined intensity values by normalization and model-based
expression (PM/MM difference model) followed by batch effect
adjustment using dChip [22,23]. The main determinant of the
data quality is the starting material: the genomic DNA must be of
high molecular weight. Call rates were in the range of 80–98%
with minus-HpaII (NspI-only) and plus-HpaII representations,
compared with lower call rates of 73–91%, as predicted, in the
plus-MspI, in which many of the SNPs dropped out as a result of
complete digestion of internal CCGG sites. Further, we observed
91% average reliability in genotype call rates across all technical
replicates with minus-HpaII treatment.
For DNA methylation analysis, SNP classes for the 500K SNP
chips were determined computationally. We used the March 2006
(hg18) build of the human genome and the SNP database to
identify the SNPs on the 250K NspI chip. These SNPs are
classified into three groups based on the presence and position of
HpaII sites within NspI fragments. Class I SNPs lack internal HpaII
sites so that they are not informative for DNA methylation but
useful as internal controls. Class 2 SNPs have at least one internal
(nonpolymorphic) HpaII site. Class 3 SNPs are identical to those in
Class 2, except these SNPs contain a polymorphic HpaII site
wherein the HpaII recognition site is potentially created or
abolished by a SNP, rendering these SNPs unreliable for use in
DNA methylation analysis. Henceforth, we only used the Class 2
SNPs since they would be affected in their amplification and
representation in the SNP chip probe preparation only by the
methylation state of the (non-polymorphic) HpaII site.
We evaluated the Class 2 SNPs experimentally by checking the
intensity ratios for plus-MspI to minus-HpaII representations. The
informative Class 2 SNPs by experiments are defined as those
SNP-tagged loci that have more than 20% decrease in the average
probe intensity ratios. Approximately 83% of the experimentally
determined Class 2 SNPs overlap with the computationally
predicted Class 2 SNPs. In this way we derived a set of empirical
Class 2 SNPs that met the criteria of being Class 2 both in silico and
in practice (a complete list of these SNPs are available by request
from the authors).
MSNP Data Analysis
The expression difference between the minus-HpaII and plus-
HpaII genomic representations indicates the methylation status of
examined SNPs. Since we had at least two technical replicates for
each brain sample, we calculated methylation index (MI), defined
as pairwise fold changes of signal intensity plus-HpaII/minus-
HpaII, and then determined the median of these pairwise MIs for
each probe within a sample. The estimated MI scores were not
truncated in the statistical analyses. We further eliminated
uninformative probes, defined as those with low coefficient of
variation (CV#10%) in the brain. For cluster analysis, we further
eliminated probes with CV#30%. Note, MI scores greater than
1.0 were adjusted to 1.0 for cluster analysis. Unsupervised
hierarchical clustering was performed using the HOPACH
package in the R statistical program [24] for hierarchical
clustering and the correlation distance as the distance metric.
For clustering analysis, MI data were log2 transformed to values
ranging from 28 to 0 corresponding to the relative level of
unmethylated and methylated states, respectively.
The difference in the methylation patterns in the neocortex and
the cerebellar cortex was assessed using a linear mixed-effects
model and evaluated by ANOVA. The mixed effect model
accounted for potential correlation in signal intensities that may
arise from having multiple brain regions from the same subject as
well as having multiple technical replicates for the same brain
regions. Significance levels for the methylation differences between
the cerebellum and other brain regions were computed via SNP-
by-SNP mixed effect models in the statistical software R (http://
www.r-project.org/). The response was the fold change of intensity
levels (MIs) for possible plus-HpaII and minus-HpaII combinations
of array representations within the same sample. Brain region was
the fixed factor, and subject ID was used as a random factor. P-
values corresponding to the F statistic (and to the pairwise t-tests)
were recorded. P-values were adjusted for multiple testing using
the Benjamini-Hochberg linear step-up procedure [25].
Supporting Information
Supplemental Materials S1
Found at: doi:10.1371/journal.pone.0011357.s001 (0.07 MB
DOC)
Figure S1 Hierarchical clustering of methylation data with
12,180 probes (with coefficient of variation, CV.0.3). The heat
map shows relative methylation differences with hypomethylated
(in red) and hypermethylated (in blue) log2(MI) scores. Dendro-
gram depicts clustering of samples by brain regions and tissues.
Found at: doi:10.1371/journal.pone.0011357.s002 (3.47 MB TIF)
Figure S2 Hierarchical clustering of methylation data with
methylation patterns of 5,284 genic probes with CV.0.3. Rows
represent probes and columns represent samples. The heat map
shows relative methylation differences with hypomethylated (in
red) and hypermethylated (in blue) log2(MI) scores. Dendrogram
depicts clustering of samples by brain regions and tissues.
Found at: doi:10.1371/journal.pone.0011357.s003 (3.48 MB TIF)
Figure S3 Methylation patterns of 9,661 probes that signifi-
cantly differentiate cerebral and cerebellar cortices with p#0.001
corrected for multiple testing. (A) Brain MI scores showing distinct
bimodal distributions for the cerebellum samples. (B) Hierarchical
clustering of methylation patterns with hypomethylated (in red)
and hypermethylated (in blue) log2(MI) scores (rows and columns
representing probes and samples, respectively). Brain regions with
similarly colored labels are from the same subjects. Dendrogram
depicts clustering by brain regions, separated by two major
branches for cerebellum and the regions of cerebral cortex.
Found at: doi:10.1371/journal.pone.0011357.s004 (7.76 MB TIF)
Figure S4 (A) Schematic representation of the human brain
depicting the DNA methylation profile of the neocortex (in blue)
and the cerebellar cortex (in red), corresponding to hyper- and
hypo-methylated states, respectively. The values depicted in the
cartoon represent the average of the MI scores across all 113 CNS
related genes identified. The values in the adjacent table
correspond to MI scores for selected CNS genes with (B)
describing the identified roles of these genes in cerebellum. The
parietal cortex (shown in gray in the cartoon below) was not
included in this study.
Brain Methylation Divergence
PLoS ONE | www.plosone.org 5 June 2010 | Volume 5 | Issue 6 | e11357Found at: doi:10.1371/journal.pone.0011357.s005 (10.77 MB
TIF)
Figure S5 Gene expression profiles for 104 genes with CpG sites
hypomethylated in cerebellum and hypermethylated in prefrontal
cortex. Gene expression density distribution are plotted in log2
scale for expression intensity values (x-axis) with lines denoting
cerebellum (in red) and cortex (in black). The expression data were
downloaded from Gene Expression Omnibus public database
(GEO accession: GSE6306).
Found at: doi:10.1371/journal.pone.0011357.s006 (2.42 MB TIF)
Table S1 Postmortem brain subjects used in the MSNP
experiments. The color coding for subjects is consistent with those
used in Figures 1, S1, S2, and S3.
Found at: doi:10.1371/journal.pone.0011357.s007 (0.03 MB
DOC)
Table S2 Probes with significant differential DNA methylation
in cerebral and cerebellar cortices. The table shows the MI scores
of samples from prefrontal (vfrnt), occipital (occ), and temporal
cortex (tmp), and the cerebellum (cer) as well as the genomic
coordinate of SNP probes. Brain regions from the same subjects
are color-coded. The genomic location of probes is categorized in
genic (overlapping gene bodies) and inter-genic regions.
Found at: doi:10.1371/journal.pone.0011357.s008 (3.29 MB
XLS)
Table S3 Probes that appear to be significantly hypomethylated
in cerebellum and hypermethylated in cerebrum. See the
description of columns in Table S2.
Found at: doi:10.1371/journal.pone.0011357.s009 (0.56 MB
XLS)
Table S4 Genic probes with known CNS function. See the
description of columns in Table S2.
Found at: doi:10.1371/journal.pone.0011357.s010 (0.07 MB
XLS)
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